Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,548.17
-13.1079-0.84%
Number of Gainers:1
Number of Losers:6
Number of Flat:- -
PE:- -
High:1,569.66
Open:1,563.81
Low:1,545.55
Close:1,561.28
Volume:46.94M
Turnover:4.25B
Market Cap:1.61T
Float Cap:1.55T

Loading ...

Pfizer Stock Eyes New Boom With Obesity And Alopecia Bets

TIPRANKS
·
Yesterday

Novo Nordisk Stock Slides as GLP-1 Fears Mount

TIPRANKS
·
Yesterday

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Yesterday

ETF Weekly | MSTZ, SMST Surge 17%; AMUU, AMDL Jump 16%; USO Advances 9%; Oil Theme Gains

ETF Weekly
·
Yesterday

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Novo Nordisk Shares Fall After Morgan Stanley Downgrade

MT Newswires Live
·
Yesterday

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
Yesterday

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Yesterday

Eli Lilly Stock (LLY) in Focus as Company Completes $3.8 Billion AtaiBeckley Purchase

TIPRANKS
·
Sep 11

Eli Lilly Completes Acquisition of AtaiBeckley

Reuters
·
Sep 11

Lilly Completes Acquisition of Ataibeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Sep 11

Political and General News Events from September 11

Reuters
·
Sep 11

U.S. Stocks on the MOVE-Novo Nordisk, Oracle, Adobe

Reuters
·
Sep 11

Novo Nordisk Stock (NVO) Falls After Morgan Stanley’s Sell Call on Market Share Loss to Eli Lilly, Patent Cliff

TIPRANKS
·
Sep 11

Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Sep 11

Morgan Stanley downgrades Novo Nordisk (0QIU) to a Sell

TIPRANKS
·
Sep 11

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Reuters
·
Sep 11

Growth Without AI: 8 Stock Picks

Dow Jones
·
Sep 11

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Sep 11